CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • Contributers

Recommended Insights

How COVID-19 will Accelerate Digital...

Jakirul Islam, Senior Vice President, Bank Asia

Sterile Processing Professional: 30 Years...

Jackie Mallatt, CRCST, Sterile Processing...

Packaging, A Key Element In Improving...

Bertrand Havrileck, Head of Corporate Pharma R&D,...

Top Biotech Developments to Watch for

Jeremy Williams, Life Science Review

What Role Does Digital Technology Play in...

Jeremy Williams, Life Science Review

Managing Risk and Minimizing the...

Timothy Korwan, Director, New Product Development...

In Personalized Medicine Logistics,...

Scott Ohanesian, Senior VP Commercial Operations,...

Unlock the Power of Data

Jijo James, M.D., M.P.H., Chief Medical Officer,...

How COVID-19 will Accelerate Digital...

Jakirul Islam, Senior Vice President, Bank Asia

Sterile Processing Professional: 30 Years...

Jackie Mallatt, CRCST, Sterile Processing...

Packaging, A Key Element In Improving...

Bertrand Havrileck, Head of Corporate Pharma R&D,...

Top Biotech Developments to Watch for

Jeremy Williams, Life Science Review

What Role Does Digital Technology Play in...

Jeremy Williams, Life Science Review

Managing Risk and Minimizing the...

Timothy Korwan, Director, New Product Development...

In Personalized Medicine Logistics,...

Scott Ohanesian, Senior VP Commercial Operations,...

Unlock the Power of Data

Jijo James, M.D., M.P.H., Chief Medical Officer,...

Leveraging Data to Improve Quality of Life

A J Vallance-owen Mbe, Frcsed, Chief Medical Officer, Medicover Ab
Tweet

There is no question that technological advances, such as the development of big data and artificial intelligence, are already driving huge changes in practical health promotion, healthcare, and health-related research, and also in academic thinking.


In health promotion, there are now a number of innovative companies which promote good health in both the non-medical and medical spaces. Data (sometimes including genetic data) is collected from interested individuals and linked to significant evidence bases to enable advice on health priorities to be delivered online. As the database of anonymised personal data grows, now increasingly including post-advice feedback from those digital customers, so does the opportunity for artificial intelligence and machine learning, in itself now enhancing the original evidence base and driving constant improvement in the advice that can be given.


If the promised improvements to health are realised, this will benefit individuals and, if the numbers scale up (e.g. if employers get involved) then, over time, there could be an impact at population level; perhaps, at last, even a start to tackling the growing cost of chronic disease in healthcare systems.


In healthcare, collection of big data is becoming big business with huge opportunities, sometimes in areas of measurement that have been little used routinely because of cost and complexity. An example is the use of Patient Reported Outcome Measures (PROMs). The principal measure of clinical outcome routinely used has, historically, been the binary measure, mortality, i.e. dead or alive. Now, with digital technology, online systems, apps, etc., it is much easier for patients routinely to report the health benefits of their treatment using PROMs, which are properly validated survey tools.


In the UK, for example, the National PROMs Programme now has a massive database covering most of the hip and knee replacements done in the UK over the last few years.


This is big data which can be used to measure patient benefit beyond ‘alive’ (particularly quality of life), the value of the procedures to the healthcare system, to drive quality improvement and to get much needed early measures of outcome for new prostheses. My company, Medicover, is now starting to use some PROMs and the potential for driving improvements in surgical care and, increasingly, in the treatment of chronic disease is high. Another early benefit has been the growing evidence that, for many people with end-stage chronic disease or terminal cancer, quality of life is as important as survivability.


Another early benefit has been the growing evidence that, for many people with end-stage chronic disease or terminal cancer, quality of life is as important as survivability


The increasing collection and use of big data could also have an impact on health-related research. Randomised controlled trials have always been the gold standard for clinical research, but they are usually conducted on carefully selected populations and managed in tightly controlled settings. Many doctors in day-to-day clinical practice say that this is not evidence from the ‘real world’ which they inhabit; whereas data gathered from unselected populations in high volume through vehicles like PROMs (with appropriate case-mix adjustment), can provide real-world evidence which might be equally or more valuable to them as prescribers.


In summary, change is a constant factor. It is no surprise that pharmaceutical companies across the world have become so interested in real-world big data and I believe that effective health promotion can now become mainstream, dead or alive should no longer be the main measure of outcome, health benefit from treatment and resulting quality of life must be the new standard, and the use of real-world big data has to find a respectable place in academic research.


Weekly Brief

loading
Towards a New World Order
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue

Read Also

The Value of New Antibiotics in the Fight Against AMR

Piero Rijli, Corporate Director, Regulatory Activities and Market Access, MENARINI Group

Improving Minimal Residual Disease Detection Using NGS

Steven Henck, Ph.D., Vice President of R&D, Integrated DNA Technologies

Multiomic Preclinical Models to Define the Mechanism of Action

Mitch Sanders, Chief Scientific Officer and EVP of the ProDevLab, at Alira Health

Developing Patient-Centric Precision Oncology Therapies: Begin With The End In Mind

Sanjay Konagurthu, Senior Director, PDS Global Science and Technology, Thermo Fisher Scientific

What the New EMA Draft "Guideline on Computerised Systems and Electronic Data" Means to Your Systems

Cathlin Shapiro, Director, Technology Quality Assurance, Parexel

Pharmaceutical Tablet Coating - Past, Present and Future

Steve Brown, Senior Director EU and APAC Global Manufacturing Science and Technology, Teva Pharmaceuticals [NYSE: TEVA]

Dynamic Commercial Aspects of Life Sciences

Jim Cooper, Director, Clinical Operations, Moderna

Achieving trial master file quality, timeliness and completeness

Susan K. Maue, Designation : Managing Director PharmaLex
Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/cxoinsight/leveraging-data-to-improve-quality-of-life-nwid-56.html